Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Larry Wayne Moreland

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Moreland, Larry

Item TypeName
Concept Necrosis
Concept Receptors, Tumor Necrosis Factor, Type I
Concept Tumor Necrosis Factor Decoy Receptors
Concept Receptors, Tumor Necrosis Factor, Type II
Concept Tumor Necrosis Factor-alpha
Concept Receptors, Tumor Necrosis Factor
Academic Article Increased pretreatment serum IFN-?/a ratio predicts non-response to tumour necrosis factor a inhibition in rheumatoid arthritis.
Concept Tumor Necrosis Factor alpha-Induced Protein 3
Academic Article Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis.
Academic Article A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
Academic Article Rheumatoid vasculitis with intrarenal aneurysm formation.
Academic Article Unmet needs in rheumatoid arthritis.
Academic Article Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
Academic Article Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Academic Article Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.
Academic Article Inhibitors of tumor necrosis factor for rheumatoid arthritis.
Academic Article Tumor necrosis factor inhibitors for rheumatoid arthritis.
Academic Article Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
Academic Article Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions.
Academic Article Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis.
Academic Article Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
Academic Article Immune function in patients with rheumatoid arthritis treated with etanercept.
Academic Article Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
Academic Article Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.
Academic Article Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
Academic Article Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.
Academic Article A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
Academic Article Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
Academic Article Genetic risk factors for infection in patients with early rheumatoid arthritis.
Academic Article Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.
Academic Article Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.
Academic Article Rheumatoid arthritis: developing pharmacological therapies.
Academic Article Access to disease modifying treatments for rheumatoid arthritis patients.
Academic Article Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Academic Article Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Academic Article Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.
Academic Article Certolizumab pegol: a new biologic targeting rheumatoid arthritis.
Academic Article Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo.
Academic Article Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.
Academic Article Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.
Academic Article Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritis.
Academic Article Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.
Academic Article Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
Academic Article Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
Academic Article Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
Academic Article Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
Academic Article Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis.
Academic Article The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
Academic Article Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Academic Article Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis.
Academic Article The treatment of rheumatoid arthritis: a review of recent clinical trials.
Academic Article B cells in rheumatoid arthritis synovial tissues encode focused antibody repertoires that include antibodies that stimulate macrophage TNF-a production.
Academic Article Upcoming biologic agents for the treatment of rheumatic diseases.
Academic Article Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
Academic Article Rheumatoid arthritis: anticytokine therapies on the horizon.
Academic Article Recent advances in anti-tumour necrosis factor (TNF) therapy in rheumatoid arthritis: focus on the soluble TNF receptor p75 fusion protein, etanercept.
Academic Article Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
Academic Article TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
Academic Article Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Academic Article Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
Grant Rheumatoid Arthritis Induction Trial (RAITMAT)
Academic Article Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis.

Search Criteria
  • Necrosis

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)